Wells Fargo
CLOV icon

Wells Fargo’s Clover Health Investments CLOV Stock Holding History

Wells Fargo’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Buy
395,057
+238,183
+152% +$809K ﹤0.01% 3577
2026
Q1 		$276K Sell
156,874
-362,096
-70% -$785K ﹤0.01% 4505
2025
Q4 		$1.22M Buy
518,970
+191,885
+59% +$524K ﹤0.01% 3819
2025
Q3 		$1M Buy
327,085
+33,769
+12% +$96.4K ﹤0.01% 3822
2025
Q2 		$818K Buy
293,316
+192,868
+192% +$634K ﹤0.01% 3824
2025
Q1 		$361K Buy
100,448
+51,300
+104% +$206K ﹤0.01% 4308
2024
Q4 		$155K Sell
49,148
-6,976
-12% -$24.9K ﹤0.01% 4941
2024
Q3 		$158K Buy
56,124
+28,100
+100% +$64.3K ﹤0.01% 4735
2024
Q2 		$34.5K Sell
28,024
-2,677
-9% -$2.4K ﹤0.01% 5425
2024
Q1 		$24.4K Buy
30,701
+63
+0.2% +$57 ﹤0.01% 5523
2023
Q4 		$29.2K Sell
30,638
-848
-3% -$833 ﹤0.01% 5490
2023
Q3 		$34K Sell
31,486
-920
-3% -$1.09K ﹤0.01% 5375
2023
Q2 		$29.1K Sell
32,406
-73,374
-69% -$65.1K ﹤0.01% 5626
2023
Q1 		$89.4K Buy
105,780
+71,240
+206% +$78K ﹤0.01% 4870
2022
Q4 		$32.1K Sell
34,540
-7,057
-17% -$9.42K ﹤0.01% 5067
2022
Q3 		$70K Sell
41,597
-15,826
-28% -$41.5K ﹤0.01% 4797
2022
Q2 		$123K Buy
57,423
+2,883
+5% +$7.66K ﹤0.01% 4526
2022
Q1 		$193K Sell
54,540
-19,769
-27% -$57.3K ﹤0.01% 4999
2021
Q4 		$276K Sell
74,309
-4,928
-6% -$30.2K ﹤0.01% 5078
2021
Q3 		$585K Buy
79,237
+10,964
+16% +$93.8K ﹤0.01% 4574
2021
Q2 		$910K Sell
68,273
-16,888
-20% -$166K ﹤0.01% 4268
2021
Q1 		$643K Sell
85,161
-25,822
-23% -$291K ﹤0.01% 4551
2020
Q4 		$1.86M Buy
110,983
+39,669
+56% +$442K ﹤0.01% 3551
2020
Q3 		$889K Buy
71,314
+51,338
+257% +$568K ﹤0.01% 3952
2020
Q2 		$223K Buy
+19,976
New +$215K ﹤0.01% 4842

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wells Fargo's CLOV Position: Q2 2026 in Review

Wells Fargo increased its Clover Health Investments (CLOV) stake by 152% in Q2 2026, buying an estimated $809K and bringing the position to 395,057 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3577.

Wells Fargo first reported a position in CLOV in Q2 2020 and has held it in 25 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Wells Fargo held 395,057 shares of Clover Health Investments worth $2.07M as of Q2 2026.
  • Wells Fargo bought 238,183 Clover Health Investments shares in Q2 2026, an estimated $809K.
  • Clover Health Investments made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3577 holding.
  • Wells Fargo first reported a position in Clover Health Investments in Q2 2020 and has held it in 25 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.